Strikingly higher interleukin (IL)-1α, IL-1β and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-α, transforming growth factor (TGF)-β2 and interferon IFN-γ, urine levels in healthy females compared to healthy males: Protection against urinary tract injury?

Clinical and Experimental Immunology

Volumn 142, Issue 2, 2005, Pages 312-317

  Sadeghi, Mahmoud ^a   Daniel, V ^a   Naujokat, C ^a   Weimer, R ^a   Opelz, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gender related differences; Protection; Scarring; Urinary tract infection; Urine IL 1 ; Urine IL 1 ; Urine sIL 1RA

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; T LYMPHOCYTE ACTIVATION; URINARY TRACT; URINARY TRACT INFECTION; URINARY TRACT INJURY;

ADULT; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX CHARACTERISTICS; SIALOGLYCOPROTEINS; URINARY TRACT INFECTIONS;

EID: 27644465185     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02924.x     Document Type: Article

References (33)

1. Gandolfo MT, Verzola D, Salvatore F et al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 2004; 56:1-14.
2. Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther 2003; 10:3-14.
3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003; 49:53-70.
4. Lynch EA, Dinarello CA, Cannon JG. Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 1994; 153:300-6.
5. Rauta V, Teppo AM, Tornroth T, Honkanen E, Gronhagen-Riska C. Lower urinary-interleukin-1 receptor-antagonist excretion in IgA nephropathy than in Henoch-Schonlein nephritis. Nephrol Dial Transplant 2003; 18:1785-91.
6. Kudo S, Goto H. Intrarenal handling of recombinant human interleukin-1alpha in rats: mechanism for proximal tubular protein reabsorption. J Interferon Cytokine Res 1999; 19:1161-8.
7. Tesch GH, Yang N, Yu H et al. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant 1997; 12:1109-15.
8. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993; 43:682-92.
9. Waldherr R, Noronha IL, Niemir Z, Kruger C, Stein H, Stumm G. Expression of cytokines and growth factors in human glomerulonephritides. Pediatr Nephrol 1993; 7:471-8.
10. Brauner A, Soderhall M, Jacobson SH, Lundahl J, Andersson U, Andersson J. Escherichia coli-induced expression of IL-1 alpha, IL-1 beta, IL-6 and IL-8 in normal human renal tubular epithelial cells. Clin Exp Immunol 2001; 124:423-8.
11. Niemir ZI, Stein H, Dworacki G et al. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int 1997; 52:393-403.
12. Fan JM, Huang XR, Ng YY et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta 1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37:820-31.
13. Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 1993; 43:479-85.
14. Lee BY, Huynh T, Prichard LE, McGuire J, Polan ML. Gonadal steroids modulate interleukin-1 receptor antagonist mRNA expression in cultured human monocytes. Biochem Biophys Res Commun 1995; 209:279-85.
15. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11:319-29.
16. Negulescu O, Bognar I, Lei J, Devarajan P, Silbiger S, Neugarten J. Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney Int 2002; 62:1989-98.
17. Lei J, Silbiger S, Ziyadeh FN, Neugarten J. Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol. Am J Physiol 1998; 274:F252-8.
18. Silbiger S, Lei J, Ziyadeh FN, Neugarten J. Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol 1998; 274:F1113-8.
19. Birch Nielsen C, Krag SO, Sterby R et al. Transforming growth factor betal-induced glomerulopathy is prevented by 17beta-estradiol supplementation. Virchows Arch 2004; 444:561-6.
20. Blush J, Lei J, Ju W, Silbiger S, Pullman J, Neugarten J. Estradiol reverses renal injury in A1b/TGF-beta1 transgenic mice. Kidney Int 2004; 66:2148-54.
21. Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann NY Acad Sci 2002; 966:131-42.
22. + T lymphocytes to increase IL-10 production. J Immunol 2001; 167:2060-7.
23. Hertting O, Khalil A, Jaremko G et al Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice. Clin Exp Immunol 2003; 131:225-33.
24. Nitschke M, Wiehl S, Baer PC, Kreft B. Bactericidal activity of renal tubular cells: the putative role of human beta-defensins. Exp Nephrol 2002; 10:332-7.
25. Tullus K, Escobar-Billing R, Fituri O et al. Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring. Acta Paediatr 1996;85:158-62.
26. van den Broek HH, Damoiseaux JG, De Baets MH, Hupperts RM. The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review. Mult Scler 2005; 11:349-59.
27. Mo R, Chen J, Grolleau-Julius A, Murphy HS, Richardson BC, Yung RL. Estrogen regulates CCR gene expression and function in T lymphocytes. J Immunol 2005; 174:6023-9.
28. Nalbandian G, Kovats S. Understanding sex biases in immunity, effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005; 31:91-106.
29. Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Estrogen and cytokines productio - the possible cause of gender differences in neurological diseases. Curr Pharm 2005; 11:1017-30.
30. Kher A, Wang M, Tsai BM et al. Sex differences in the myocardial inflammatory response to acute injury. Shock 2005; 23:1-10.
31. Sadeghi M, Daniel V, Naujokat C, Wiesel M, Hergesell O, Opelz G. Strong inflammatory cytokine response in male and strong antiinflamatory response in female kidney transplant recipients with urinary tract infection. Transpl Int 2005; 18:177-85.
32. Arend WP. The balance between IL-1 and IL-1RA in disease. Cytokine Growth Factor Rev 2002; 13:323-40.
33. Kluth DC, Rees AJ. New approaches to modify glomerular inflammation. J Nephrol 1999; 12:66-75.